{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T15:25:46Z","timestamp":1794756346507,"version":"4.9.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_185029"],"award-info":[{"award-number":["310030_185029"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multimodal treatment, including systemic treatment and surgery, improved the prognosis of peritoneal metastasis (PM). Despite all efforts, recurrence rates remain high, and little data are available about clinical behavior or molecular patterns of PM in comparison to hematogenous metastasis. Here, we aimed to analyze recurrence patterns after multimodal treatment for PM from colorectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with colorectal PM undergoing multimodal treatment including systemic chemotherapy and cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) between 2005 and 2017 at 4 centers were analyzed retrospectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 505 patients undergoing CRS\/HIPEC were analyzed. Of the patients, 82.1% received preoperative chemotherapy. Median peritoneal cancer index was 6 (interquartile range = 3-11). Median disease-free and overall survival was 12\u2009(95% confidence interval [CI] = 11 to 14) months and 51 (95% CI = 43 to 62) months, respectively. Disease recurred in 361 (71.5%) patients, presenting as isolated peritoneal recurrence in 24.6%, isolated hematogenous recurrence in 28.3%, and mixed recurrence in 13.9% of patients. Recurrence to the peritoneum was associated with an impaired time from recurrence to death of 21\u2009(95% CI = 18 to 31) months for isolated peritoneal and 22\u2009(95% CI = 16 to 30) months for mixed recurrence, compared with 43\u2009(95% CI = 31 to &amp;gt;121) months for hematogenous recurrence (hazard ratio [HR] = 1.79, 95% CI = 1.27 to 2.53; P\u2009=\u2009.001; and HR = 2.44, 95% CI = 1.61 to 3.79; P\u2009&amp;lt;\u2009.001). On multiple logistic regression analysis, RAS mutational status (odds ratio [OR] = 2.42, 95% CI = 1.11 to 5.47; P\u2009=\u2009.03) and positive nodal stage of the primary (OR = 3.88, 95% CI = 1.40 to 11.86; P\u2009=\u2009.01) were identified as predictive factors for peritoneal recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights the heterogeneity of peritoneal metastasis in patients with colorectal cancer. Recurrent peritoneal metastasis after radical treatment represents a more aggressive subset of metastatic colorectal cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djab001","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T15:18:47Z","timestamp":1610723927000},"page":"1027-1035","source":"Crossref","is-referenced-by-count":61,"title":["Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis"],"prefix":"10.1093","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7813-5149","authenticated-orcid":false,"given":"Eva","family":"Breuer","sequence":"first","affiliation":[{"name":"Department of Surgery & Transplantation, Surgical Oncology Research Laboratory, University Hospital of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3843-1629","authenticated-orcid":false,"given":"Monika","family":"Hebeisen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6723-8879","authenticated-orcid":false,"given":"Marcel Andr\u00e9","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Surgery & Transplantation, Surgical Oncology Research Laboratory, University Hospital of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Roth","sequence":"additional","affiliation":[{"name":"Department of Surgery & Transplantation, Surgical Oncology Research Laboratory, University Hospital of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Pauli","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Pathology, University Hospital Z\u00fcrich, Zurich, Switzerland"},{"name":"University of Zurich (UZH), Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Frischer-Ordu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Pathology, University Hospital Z\u00fcrich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Eden","sequence":"additional","affiliation":[{"name":"Department of Surgery,\u00a0Cantonal Hospital of St Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Pache","sequence":"additional","affiliation":[{"name":"Department\u00a0of Surgery, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Steffen","sequence":"additional","affiliation":[{"name":"Department of Surgery,\u00a0Cantonal Hospital of St Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00fcbner","sequence":"additional","affiliation":[{"name":"Department\u00a0of Surgery, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Villeneuve","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University Hospital of Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9885-8600","authenticated-orcid":false,"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University Hospital of Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Passot","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University Hospital of Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gertsch","sequence":"additional","affiliation":[{"name":"Department of Surgery & Transplantation, Surgical Oncology Research Laboratory, University Hospital of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Surgery & Transplantation, Surgical Oncology Research Laboratory, University Hospital of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University Hospital of Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6177-9543","authenticated-orcid":false,"given":"Kuno","family":"Lehmann","sequence":"additional","affiliation":[{"name":"Department of Surgery & Transplantation, Surgical Oncology Research Laboratory, University Hospital of Zurich, Zurich, Switzerland"},{"name":"University of Zurich (UZH), Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"issue":"2","key":"2021080303212358500_djab001-B1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"issue":"10","key":"2021080303212358500_djab001-B2","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.ejso.2017.05.010","article-title":"An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland","volume":"43","author":"Solon","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"2021080303212358500_djab001-B3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1470-2045(17)30336-4","article-title":"Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer","volume":"18","author":"Tseng","year":"2017","journal-title":"Lancet Oncol"},{"issue":"9","key":"2021080303212358500_djab001-B4","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"2021080303212358500_djab001-B5","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8","key":"2021080303212358500_djab001-B6","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1245\/s10434-017-5821-7","article-title":"Major postoperative complications are a risk factor for impaired survival after CRS\/HIPEC","volume":"24","author":"Schneider","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2021080303212358500_djab001-B7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"2021080303212358500_djab001-B8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"issue":"12","key":"2021080303212358500_djab001-B9","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"10","key":"2021080303212358500_djab001-B10","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/annonc\/mdq762","article-title":"Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy","volume":"22","author":"Klaver","year":"2011","journal-title":"Ann Oncol"},{"issue":"2","key":"2021080303212358500_djab001-B11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<375::AID-CNCR18>3.0.CO;2-W","article-title":"Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production","volume":"82","author":"Laeng","year":"1998","journal-title":"Cancer"},{"issue":"7","key":"2021080303212358500_djab001-B12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/bjc.2017.37","article-title":"Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer","volume":"116","author":"Jones","year":"2017","journal-title":"Br J Cancer"},{"issue":"12","key":"2021080303212358500_djab001-B13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.prp.2009.07.010","article-title":"Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer","volume":"205","author":"Neumann","year":"2009","journal-title":"Pathol Res Pract"},{"issue":"9","key":"2021080303212358500_djab001-B14","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/annonc\/mdw261","article-title":"Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group","volume":"27","author":"Modest","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"2021080303212358500_djab001-B15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"1","key":"2021080303212358500_djab001-B16","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1038\/s41598-018-24306-1","article-title":"Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients","volume":"8","author":"Guo","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"2021080303212358500_djab001-B17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","article-title":"Clinical sequencing defines the genomic landscape of metastatic colorectal cancer","volume":"33","author":"Yaeger","year":"2018","journal-title":"Cancer Cell"},{"issue":"5","key":"2021080303212358500_djab001-B18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"2021080303212358500_djab001-B19","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"6","key":"2021080303212358500_djab001-B20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/SLA.0b013e31827e9289","article-title":"Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?","volume":"257","author":"Go\u00e9r\u00e9","year":"2013","journal-title":"Ann Surg"},{"issue":"5","key":"2021080303212358500_djab001-B21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"2021080303212358500_djab001-B22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jso.23597","article-title":"Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"109","author":"Braam","year":"2014","journal-title":"J Surg Oncol"},{"issue":"1","key":"2021080303212358500_djab001-B23","first-page":"72","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection","volume":"7","author":"Esquivel","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"2021080303212358500_djab001-B24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1245\/ASO.2004.08.014","article-title":"Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome","volume":"11","author":"Verwaal","year":"2004","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2021080303212358500_djab001-B25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/SLA.0000000000002899","article-title":"Mutations of RAS\/RAF proto-oncogenes impair survival after cytoreductive surgery and HIPEC for peritoneal metastasis of colorectal origin","volume":"268","author":"Schneider","year":"2018","journal-title":"Ann Surg"},{"issue":"39","key":"2021080303212358500_djab001-B26","doi-asserted-by":"crossref","first-page":"14371","DOI":"10.3748\/wjg.v20.i39.14371","article-title":"Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?","volume":"20","author":"Terzi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2021080303212358500_djab001-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40644-018-0187-z","article-title":"Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases","volume":"19","author":"Dresen","year":"2019","journal-title":"Cancer Imaging"},{"issue":"8","key":"2021080303212358500_djab001-B28","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/bjc.2013.118","article-title":"KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers","volume":"108","author":"Phipps","year":"2013","journal-title":"Br J Cancer"},{"issue":"7","key":"2021080303212358500_djab001-B29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41588-019-0423-x","article-title":"Quantitative evidence for early metastatic seeding in colorectal cancer","volume":"51","author":"Hu","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"2021080303212358500_djab001-B30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1245\/s10434-007-9591-5","article-title":"Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis","volume":"15","author":"Rekhraj","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2021080303212358500_djab001-B31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12307-008-0007-2","article-title":"Role of cancer microenvironment in metastasis: focus on colon cancer","volume":"1","author":"Gout","year":"2008","journal-title":"Cancer Microenviron"},{"issue":"12","key":"2021080303212358500_djab001-B32","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1007\/s10350-004-0723-8","article-title":"Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival","volume":"47","author":"Baskaranathan","year":"2004","journal-title":"Dis Colon Rectum"},{"issue":"6346","key":"2021080303212358500_djab001-B33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.aai8515","article-title":"Origins of lymphatic and distant metastases in human colorectal cancer","volume":"357","author":"Naxerova","year":"2017","journal-title":"Science"},{"issue":"25","key":"2021080303212358500_djab001-B34","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Origins of cancer: molecular basis of colorectal cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N Engl J Med"},{"key":"2021080303212358500_djab001-B35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ebiom.2019.01.050","article-title":"Biomarker concordance between primary colorectal cancer and its metastases","volume":"40","author":"Bhullar","year":"2019","journal-title":"EBioMedicine"},{"issue":"2","key":"2021080303212358500_djab001-B36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7314\/APJCP.2016.17.2.539","article-title":"Value of KRAS, BRAF, and PIK3CA mutations and survival benefit from systemic chemotherapy in colorectal peritoneal carcinomatosis","volume":"17","author":"Sasaki","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"2021080303212358500_djab001-B37","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3748\/wjg.v22.i5.1745","article-title":"Colorectal cancer tumour markers and biomarkers: recent therapeutic advances","volume":"22","author":"Lech","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"20","key":"2021080303212358500_djab001-B38","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/cncr.26086","article-title":"Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer","volume":"117","author":"Tran","year":"2011","journal-title":"Cancer"},{"issue":"15","key":"2021080303212358500_djab001-B39","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2010.33.5091","article-title":"Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status","volume":"29","author":"Van Cutsem","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"2021080303212358500_djab001-B40","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer","volume":"369","author":"Douillard","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"2021080303212358500_djab001-B41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nm.3870","article-title":"Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients","volume":"21","author":"Siravegna","year":"2015","journal-title":"Nat Med"},{"issue":"7404","key":"2021080303212358500_djab001-B42","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","article-title":"Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer","volume":"486","author":"Misale","year":"2012","journal-title":"Nature"},{"issue":"11","key":"2021080303212358500_djab001-B43","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N Engl J Med"},{"issue":"17","key":"2021080303212358500_djab001-B44","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-RAS mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N Engl J Med"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djab001\/36330515\/djab001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/113\/8\/1027\/39544323\/djab001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/113\/8\/1027\/39544323\/djab001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T23:22:49Z","timestamp":1627946569000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/113\/8\/1027\/6117327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,1,23]]},"published-print":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djab001","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,1,23]]}}}